Cargando…
Further discussion on glucocorticoid treatment of COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433069/ https://www.ncbi.nlm.nih.gov/pubmed/36044381 http://dx.doi.org/10.1097/CM9.0000000000001872 |
| _version_ | 1784780543002411008 |
|---|---|
| author | Feng, Yun’ai Li, Haichao |
| author_facet | Feng, Yun’ai Li, Haichao |
| author_sort | Feng, Yun’ai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9433069 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94330692022-09-01 Further discussion on glucocorticoid treatment of COVID-19 Feng, Yun’ai Li, Haichao Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-06-05 2021-12-21 /pmc/articles/PMC9433069/ /pubmed/36044381 http://dx.doi.org/10.1097/CM9.0000000000001872 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Correspondence Feng, Yun’ai Li, Haichao Further discussion on glucocorticoid treatment of COVID-19 |
| title | Further discussion on glucocorticoid treatment of COVID-19 |
| title_full | Further discussion on glucocorticoid treatment of COVID-19 |
| title_fullStr | Further discussion on glucocorticoid treatment of COVID-19 |
| title_full_unstemmed | Further discussion on glucocorticoid treatment of COVID-19 |
| title_short | Further discussion on glucocorticoid treatment of COVID-19 |
| title_sort | further discussion on glucocorticoid treatment of covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433069/ https://www.ncbi.nlm.nih.gov/pubmed/36044381 http://dx.doi.org/10.1097/CM9.0000000000001872 |
| work_keys_str_mv | AT fengyunai furtherdiscussiononglucocorticoidtreatmentofcovid19 AT lihaichao furtherdiscussiononglucocorticoidtreatmentofcovid19 |